Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220766
Status:
COMPLETED
Last Update Posted:
2009-09-25
First Post:
2005-09-13
Brief Title:
Rapid Infusion of Immune Globulin Intravenous Human In Primary Immunodeficiency Patients
Sponsor:
Grifols Therapeutics LLC
Organization:
Grifols Therapeutics LLC
Organization Data
Organization:
Grifols Therapeutics LLC
Class:
INDUSTRY
Study ID:
100348
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grifols Therapeutics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gerald Klein MD Chief Medical Officer Vice President of Medical and Clinical Affairs
Old Organization:
Talecris Biotherapeutics Inc